Sono-Tek reports financial results for the second-quarter ended August 31, 2009

Sono-Tek Corporation (OTC Bulletin Board: SOTK) today announced sales of $1,683,883 for the three months ended August 31, 2009, compared to sales of $1,605,482 for the prior year period, an increase of $78,401 or 5%. Sales also increased versus our first quarter by $219,155 or 15% in coating equipment for alternative energy, medical device equipment, food processing equipment and other industrial coating equipment. The latter two areas are also "green" in that we are displacing wasteful conventional spraying systems with our ultrasonic atomization technology. The Company reported net income of $40,546 for the three months ended August 31, 2009 compared to a loss of ($177,296) for the three months ended August 31, 2008. The current period profit resulted from higher sales volume combined with previous cost reductions and a reduced break-even point.

Dr. Christopher L. Coccio, Sono-Tek's Chairman and CEO, commented that "We announced in recent communications a goal of bringing the business back to a profitable mode again, and we are now achieving it. We spent money last year to build new technology, market, and business segments, and these efforts are now paying off for us. Senior management also took voluntary pay reductions at the beginning of this fiscal year to demonstrate our commitment to the future, and these are still in place. As we look at the next quarter, we expect both another double digit increase in our sales, as well as stronger profits."

Source:

Sono-Tek Corporation

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scaling B-cell cloning workflows for antibody development